CTH is just presenting data without too much interpretation on this study, because it could be analyzed two separate ways.
A Denmark study of vaccine effectiveness (VE) to “prevent infection“, and that’s a key point, shows both the Pfizer and Moderna vaccine benefits essentially disappear after 90 days to six months. [Study pdf Here] Now, some people are interpreting the bottom line result to say the vaccine makes you more susceptible to Omicron variant infection after the 150 day point [SEE HERE]. However, I’m not sure that’s the key takeaway.
The data does show that during the 91 to 150 day waning period of vaccine effectiveness, the vaccinated group who used Pfizer were 76.5% more likely to be infected with a variant versus the unvaccinated population. And the vaccinated group who used Moderna were 39.3% more likely to be infected with a variant versus the unvaccinated population. [Note, all natural immunity groups (previously infected) were removed from the study]

Yes, the study shows the vaccinated groups are more likely to be infected with Omicron than the unvaccinated population.
However, ¹if the Pfizer vaccinated group within the total population is at or near 76%, and ¹if the Moderna vaccinated group within the total population is at or near 39%, then what this Denmark study actually shows is a non-existent benefit from vaccination toward the Omicron variant. Not, and I repeat NOT, a finding that the vaccination itself makes you more prone to infection from Omicron.
What we need to know is how many people in the total population are vaccinated, AND what percentage of that total vaccinated population used Pfizer and Moderna.
If the total population Omicron infection rates for both Pfizer and Moderna groups mirror the vaccination rates for Pfizer and Moderna, then the vaccine effectiveness is nil for the prevention of Omicron infection. To me, that seems the most likely scenario.
The study conclusion is that booster shots are needed and provide essentially a 54.6% reduction in the risk of Omicron infection for Pfizer, and a (small sample) 82.8% reduction of the risk of Omicron infection for the Moderna group.
From the perspective of the global governing elite, a widespread Omicron variant might disrupt their services…. Something must be done.



